NEMUS Announces Research Agreement With the University of Mississippi to Develop Proprietary Cannabidiol (CBD) Molecules
Marketwired - Tue Jul 07, 7:31AM CDT
NEMUS Bioscience, Inc. (OTCQB: NMUS) announced the signing of a research agreement with the University of Mississippi (UM) to study and conduct research and development on cannabidiol (CBD) containing formulations.
NEMUS Bioscience, Inc. to Present on Cannabis Investor Webcast
ACCESSWIRE - Wed Jun 03, 11:15AM CDT
COSTA MESA, CA / ACCESSWIRE / June 3, 2015 / NEMUS Bioscience Inc. (NMUS) is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids, designed to alleviate a variety of diseases and symptoms by selectively targeting CB1 and CB2 receptors. NEMUS Bioscience, Inc. will be presenting on the Cannabis Investor Webcast on Thursday, June 4, 2015 at 3:00 PM ET.
Is Nemus Bioscience An Investment Opportunity In The Cannabis Space?
Nick Cox - at Seeking Alpha - Mon Jun 01, 1:46PM CDT
GWPH: 125.86 (+5.39)
Nemus Bioscience: Former President Of Allergan Will Lend Further Expertise From The Board
Dallas Salazar - at Seeking Alpha - Mon Jun 01, 1:14PM CDT
NEMUS Bioscience Announces Appointment of Douglas S. Ingram, Former President of Allergan, to Its Board of Directors
Marketwired - Mon Jun 01, 7:02AM CDT
NEMUS Bioscience, Inc. (OTCQB: NMUS) announced the appointment of Douglas S. Ingram, former President of Allergan Inc., to its Board of Directors in the newly created role of Vice Chairman. Mr. Ingram has also agreed to and has been appointed to serve as Chair of the Compensation and Compliance Committee of the Board of Directors.
AGN: 312.13 (+8.03)
NEMUS Bioscience: A Unique Approach To The 32 Million Rx U.S. Glaucoma Market
Dallas Salazar - at Seeking Alpha - Fri May 15, 11:42AM CDT
NEMUS Bioscience, Inc. to Attend Upcoming Investment Conferences
Marketwired - Fri May 15, 7:00AM CDT
NEMUS Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids for the treatment of glaucoma, announces that it has been invited to, and will attend, three investor conferences where they will present and conduct one-on-one meetings with investors in May and June.
Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part VII
Anthony Cataldo - at Seeking Alpha - Sun Apr 19, 11:06PM CDT
NEMUS Bioscience, Inc. Retains MZ Group as Investor Relations Advisor
GlobeNewswire - Tue Mar 24, 6:09AM CDT
NEMUS Bioscience Inc. (OTCQB: NMUS), a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids, announced today it has retained MZ Group as its investor relations advisor.
NEMUS Bioscience, Inc. initiates anti-infective program with focus on MRSA
GlobeNewswire - Wed Mar 18, 6:06AM CDT
NEMUS Bioscience, Inc. (OTCQB: NMUS) announced today that the company would begin studies concerning the medical utility of cannabinoids as anti-infective therapeutics. The initial studies will be performed at the University of Mississippi (UM), a NEMUS strategic collaborative partner and a global leader in the chemistry and science of cannabinoids and botanicals.
Cannabis - The Good, The Bad And The Ugly
Nick Cox - at Seeking Alpha - Mon Mar 09, 4:02AM CDT
INSY: 37.53 (+0.49), GWPH: 125.86 (+5.39)
48 Marijuana Stocks - A Post-Mortem: Part I
Anthony Cataldo - at Seeking Alpha - Tue Mar 03, 1:27AM CST
GWPH: 125.86 (+5.39)
Nemus Unlocks Cannabinoid Potential with Unique Compound
ACCESSWIRE - Tue Feb 17, 8:33AM CST
WHITEFISH, MT / ACCESSWIRE / February 17, 2015 / The market for legalized marijuana grew 74% from $1.5 billion in 2013 to $2.7 billion in 2014, according to ArcView Market Research, with medical marijuana accounting for over 80% of the market. These growth rates are being driven by favorable legislation across the country and growing public support for the legalization of both adult-use and medical marijuana, although there's still strong opposition by a lot of conservatives in the government.
GWPH: 125.86 (+5.39), AMGN: 154.10 (+2.79), GSK: 42.45 (+0.65)
StockNewsNow.com Publishes New SNNLive Video Interview with NEMUS Bioscience, Inc.
ACCESSWIRE - Wed Feb 11, 7:31AM CST
LOS ANGELES, CA / ACCESSWIRE / February 11, 2015 / StockNewsNow.com, the Official MicroCap News Source, today published an SNNLive Video Interview with John Hollister, CEO of NEMUS Bioscience, Inc. (OTCBB: NMUS), a biopharmaceutical company focused on the discovery, development, and the commercialization of cannabis-based therapeutics through partnership with the University of Mississippi for the treatment of a variety of diseases or symptoms suffered by many around the globe. The video interview was recorded in San Francisco, CA at the Healthcare Media Day.